Areas of expertise
Recent work
Lorna advises clients on a broad range of EU and UK competition law matters including mergers and acquisitions, antitrust investigations, subsidy control and competition litigation.
Highlights
- Allergan on its acquisition by Abbvie
- IAG in relation to the CMA antitrust investigation into the Atlantic Joint Business Agreement, and on its proposed acquisition of Air Europa
- Illumina on its acquisition of Grail, including on appeal to the European Courts
- JPMorgan Chase Bank in relation to litigation arising out of the forex investigations
- Platts in the EC’s oil and biofuel investigations
- Schneider Electric on its acquisition of Aveva and various other acquisitions and disposals
- UnitedHealth on the CMA Phase 2 unconditional clearance for takeover of EMIS
- Viatris on the CMA conditional clearance in relation to its sale of the European rights to its Femoston and Duphaston products to Theramex.
Lorna has been named by Global Competition Review in their 40 under 40 survey of leading antitrust practitioners and their 40 under 40 survey of leading foreign investment control lawyers. Lorna was also listed by Empower in their list of 100 Future Leaders Role Model in 2022 and is a supporting Partner of the firm’s Diverse Network (a Network aimed at celebrating and promoting ethnic and racial diversity). She is a member of the Brussels Bar (A list), as well as being qualified as a solicitor (England and Wales).